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Abstract
Introduction
HIV-1 prevention programs targeting HIV-1 serodiscordant couples need to identify couples
that are likely to become pregnant to facilitate discussions about methods to minimize HIV-
1 risk during pregnancy attempts (i.e. safer conception) or effective contraception when
pregnancy is unintended. A clinical prediction tool could be used to identify HIV-1 serodis-
cordant couples with a high likelihood of pregnancy within one year.
Methods
Using standardized clinical prediction methods, we developed and validated a tool to iden-
tify heterosexual East African HIV-1 serodiscordant couples with an increased likelihood
of becoming pregnant in the next year. Datasets were from three prospectively followed
cohorts, including nearly 7,000 couples from Kenya and Uganda participating in HIV-1 pre-
vention trials and delivery projects.
Results
The final score encompassed the age of the woman, woman’s number of children living,
partnership duration, having had condomless sex in the past month, and non-use of an
effective contraceptive. The area under the curve (AUC) for the probability of the score
to correctly predict pregnancy was 0.74 (95% CI 0.72–0.76). Scores7 predicted a
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pregnancy incidence of >17% per year and captured 78% of the pregnancies. Internal and
external validation confirmed the predictive ability of the score.
Discussion
A pregnancy likelihood score encompassing basic demographic, clinical and behavioral
factors defined African HIV-1 serodiscordant couples with high one-year pregnancy inci-
dence rates. This tool could be used to engage African HIV-1 serodiscordant couples in
counseling discussions about fertility intentions in order to offer services for safer concep-
tion or contraception that align with their reproductive goals.
Introduction
Pregnancy and the birth of healthy children are important aspirations for many couples,
including those affected by HIV-1. For HIV-1 serodiscordant couples (i.e. couples in which
one partner is HIV-1 infected and the other is not), the risk of HIV-1 transmission is height-
ened during pregnancy and the period leading up to pregnancy.[1–3] Despite the risk for
HIV-1 transmission that accompanies pregnancy attempts—specifically, times when couples
reduce or entirely forgo condom use—the achievement of fertility goals is paramount for
couples; indeed, pregnancy rates among HIV-1 serodiscordant couples are similar to the gen-
eral population.[4, 5] For HIV-1 serodiscordant couples with fertility goals, an early strategy
is to engage them in discussion about their fertility desires and timing so that appropriate rec-
ommendations about safer conception services or effective contraception can be made. Key
safer conception interventions for low resource settings include antiretroviral therapy (ART)
use by the HIV-1 infected partner, pre-exposure prophylaxis (PrEP) for the HIV-1 unin-
fected partner and condomless sex limited to periods with peak fertility.[6, 7] Additional
interventions, including fertility screening, diagnostic testing with treatment for genital infec-
tions, and vaginal self-insemination can further reduce risk and are consistent with a harm
reduction approach.[8, 9]
Half of all new HIV-1 infections in sub-Saharan Africa are estimated to occur in stable het-
erosexual relationships, making HIV-1 serodiscordant couples a priority target population for
HIV-1 prevention interventions [10, 11]. While strategies exist to minimize HIV-1 risk for
HIV-1 serodiscordant couples planning pregnancy, a challenge lies in identifying couples
who may soon become pregnant in order to initiate discussions about fertility desires. Timely
counseling can help direct couples towards safer conception interventions (in the event that
pregnancy is desired) or contraception (if pregnancy is not immediately desired). Worldwide,
40% of pregnancies are estimated to be unintended [12]. Public health systems may benefit
from a simple tool that uses easy-to-capture information to identify couples likely to become
pregnant. [13]
Clinical prediction tools have been developed to aid providers in identifying persons at risk
for clinical outcomes, including, in reproductive health, pregnant women at risk of operative
delivery and preeclampsia.[14, 15] However, a tool has not been developed to identify couples
who are most likely to become pregnant. We used standardized clinical prediction methods to
generate and validate a simple tool to identify heterosexual East African HIV-1 serodiscordant
couples with increased likelihood of becoming pregnant in the next one year.[16, 17]
A Pregnancy Likelihood Score
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Methods
Data from three prospectively followed cohorts of East African heterosexual HIV-1 serodiscor-
dant couples were used to derive and externally validate a pregnancy prediction model. Cou-
ples included those with HIV-1 infected women at risk of HIV-1 transmission to male partners
as well as those with uninfected women at risk of HIV-1 acquisition. Participants were18
and sexually active and HIV-1 infected partners were not using ART at enrollment. Inter-
viewer-administered standardized questionnaires were used to obtain information about
demographics, medical history and symptoms, sexual behavior and contraceptive use. Across
studies, participants received comprehensive HIV-1 prevention services including individual
and couples counseling, free condoms and treatment of sexually transmitted infections (STI) at
all visits.
In the Partners PrEP Study (derivation cohort), pregnancy testing was conducted on a
monthly basis for HIV-1 uninfected women and as clinically indicated during quarterly study
visits for HIV-1 infected women. This cohort consisted of 4747 HIV-1 serodiscordant couples
from 9 sites in Kenya and Uganda who were participating in a randomized clinical trial of daily
oral pre-exposure prophylaxis (PrEP) for HIV-1 prevention [18, 19]. For HIV-1 uninfected
women, routine visit procedures included HIV-1 testing, study drug dispensing, and adherence
counseling; blinded study drug was withheld during pregnancy and breastfeeding. HIV-1
infected women underwent 6-monthly CD4 count and HIV-1 RNA testing.
In the Partners in Prevention HSV/HIV Transmission Study (external validation cohort),
pregnancy testing was conducted quarterly for the 3408 women from 14 sites in 7 East and
southern African countries who were participating in this randomized trial of daily acyclovir to
prevent HIV-1 transmission from partners dually-infected with HSV-2 and HIV-1 [20, 21].
HIV-1 infected partners completed monthly study visits for study drug dispensation and
adherence counseling and HIV-1 uninfected partners completed quarterly study visits for
HIV-1 testing. To validate the pregnancy prediction model with this cohort, data were
restricted to the 1760 couples from Kenyan and Ugandan sites.
In the ongoing Partners Demonstration Project (external validation cohort), pregnancy test-
ing is conducted for all women at enrollment and as clinically indicated during quarterly fol-
low-up visits. Information on fertility intention is collected for all participants through a
standardized interviewer-administered questionnaire asking if the participant desires another
child in the future and when he/she would like to have a future child. In this implementation
science-driven delivery project of PrEP as a “bridge” to ART use, 1013 high risk HIV-1 serodis-
cordant couples from 4 sites in Kenya and Uganda are followed for up to 24 months to assess
their use of PrEP in a time-limited fashion until the HIV-1 infected partner initiates and sus-
tains ART use [22]. To validate the pregnancy prediction model with this cohort, we included
data through December 2014.
Score derivation
Using univariate Cox proportional hazards models, we identified enrollment demographic,
medical, and sexual behavior characteristics from female and male partners of participants in
the Partners PrEP Study that predicted the first occurrence of a new pregnancy using a p-value
cutoff of 0.05. We limited consideration of possible predictors to baseline characteristics so
that the final tool would use information that could be routinely captured during an initial
clinic visit. Pregnancy was defined to begin on the self-reported date of last menstrual period
(LMP), for most pregnancies, or for those without LMP data, by counting backwards from the
date of delivery based using the reported gestational age that the pregnancy achieved. Follow-
up time was censored after the occurrence of a woman’s first pregnancy and after one year in
A Pregnancy Likelihood Score
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the study. Continuous variables were grouped into the most predictive categories using optimal
cutpoints identified through signal detection receiver operating characteristic (ROC) curves.
[23] Categories covering few integers were collapsed to ensure that the final scoring tool would
be easy to apply in a clinic setting.
All factors identified as predictive in univariate analysis were combined into a multivariate
Cox proportional hazards model and a fully stepwise sequence selection procedure was used to
identify the most predictive combination of factors. When two co-linear factors were identified
through univariate analysis, we chose the factor that would be most simple to obtain from a
woman to ensure that the final model would be feasible to implement. The Akaike Information
Criterion (AIC) was used to identify the most predictive model (with the lowest AIC). To
derive the score value for each category within predictors, we divided each coefficient from the
multivariate proportional hazards model by the lowest coefficient among all predictors and
rounded to the nearest integer.
Once we identified the most predictive model and scores for each predictor category, we
applied the score to each woman in the dataset and calculated her pregnancy likelihood score.
Pregnancy incidence rates were calculated as the number of new pregnancies occurring within
one year of follow-up divided by the total time accrued between enrollment and pregnancy or
one year for women who did not become pregnant. Score categories were determined by col-
lapsing adjacent score levels that had similar incidence rates. We used ROC analysis to calcu-
late the area under the curve (AUC) with the score as the sole predictor of pregnancy.
Validation
We used a 10-fold cross validation technique to check for internal consistency of AUC within
the derivation cohort. For external validation, we applied the score to enrollment data from
participants from Kenyan and Ugandan sites in the Partners in Prevention HSV/HIV Trans-
mission Study and the Partners Demonstration Project and calculated the pregnancy score
for each woman. For each validation dataset, we calculated the AUC with the score as the sole
predictor of pregnancy and pregnancy incidence rates for each category of the score. Women
pregnant at enrollment were excluded and follow-up time was censored at one year in both
external validation datasets.
Assessing fertility intentions could be a simple alternative method to predict upcoming
pregnancy. However, it is unclear if this would be as predictive as a compilation of factors
incorporated into one tool due to the frequency of unintended pregnancies and often changing
pregnancy goals. Using data from the Partners Demonstration Project, we examined the pre-
dictive ability of fertility intentions by calculating the AUC for pregnancy prediction with a
binary variable of immediate fertility intention (desiring a child within 1 year) as the sole
predictor.
All analyses were conducted using SAS 9.4 (Cary, NC) and public domain ROC5 (Depart-
ment of Veteran’s Affairs and the National Institute of Aging of the United States of America).
Protocols for each study were approved by the University of Washington Human Subjects
Division and ethics review committees for each of the study sites. Participants provided written
informed consent.
Results
Participant characteristics
In the Partners PrEP Study, 58.9% of couples had an HIV-1 infected woman, the median age of
women was 31 (interquartile range [IQR]: 26–36), most couples had at least 1 child together,
and the median duration of partnerships was 8 years (IQR: 4–15, Table 1). Women reported a
A Pregnancy Likelihood Score
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median of 4 sex acts with their partner in the month prior to enrollment and approximately
one-quarter reported at least one sex act with their partner that was unprotected by a condom.
Of the 4,340 couples whose female partner was not pregnant at enrollment, 600 (13.8%)
became pregnant during the first year of follow up and the pregnancy incidence was 15.0 (95%
confidence interval [CI] 13.8–16.2) per 100 person-years.
Score derivation model
Univariate analysis identified multiple factors significantly associated with incident pregnancy
within one year (Table 2). In a stepwise duration, woman’s number of children, having had sex
unprotected by a condom in the past month, Cox proportional hazards multivariate model,
five factors were retained for the final prediction model: woman’s age, partnership and non-use
of an effective contraceptive. The highest value for an individual risk factor was 6 for women
aged 18–27, with other factors scoring at lower values (Fig 1). Notably, HIV-1 status did not
emerge as a key predictor.
We applied the scores for each predictor to enrollment data from women in the Partners
PrEP Study and calculated the pregnancy incidence for women in each level of the score. Half
of the couples had a score of7 and this score captured 78% of the pregnancies that occurred
during follow-up; scores13 predicted a pregnancy incidence>50% per year (Fig 2, panel A).
The composite score had greater predictability than any of the individual factors alone (Fig 3).
Table 1. Characteristics of couples participating in studies used for score derivation and validation.
Partners PrEP
Study
Partners in Prevention HSV/HIV Transmission
Study, Kenyan and Ugandan sites
Partners
Demonstration Project
Number of couples 4340 1760 872
% with HIV-1 infected women 2555 (58.9%) 1191 (67.7%) 538 (61.7%)
Woman’s age, Median (IQR) 31 (26–36) 29 (25–35) 27 (23–33)
Women’s number of children, Median (IQR) 3 (2–5) 2 (1–4) 2 (1–3)
Couple’s number of children, Median (IQR) 2 (1–4) 1 (1–3) 0 (0–2)
Partnership duration, years, Median (IQR) 8 (4–15) 6 (3–11) 4 (1–8)
% Married or cohabiting 4292 (98.9%) 1717 (97.6%) 851 (97.6%)
Years of school completed by the woman, Median
(IQR)
7 (3–8) 8 (6–10) 8 (6–11)
Sex acts between study partners, past month,
Median (IQR)*
4 (2–8) 3 (2–6) 5 (3–10)
% couples having at least 1 sex act without a
condom, past month*
1091 (25.2%) 475 (27.0%) 548 (62.8%)
% women reporting a non-study sexual partner, past
month
37 (0.9%) 16 (1.0%) 12 (1.4%)
% women using effective contraception (injectable,
oral, IUD, implant, or surgical method)
1776 (40.9%) 338 (19.2%) 273 (35.2%)
% women with an STI** 433 (10.3%) 157 (9.5%) —
% of HIV-1 uninfected women with HSV-2
infection**
1398 (80.3%) 492 (88.8%) —
% experiencing pregnancy during follow-up 600 (13.8%) 312 (17.7%) 141 (16.2%)
One year pregnancy incidence rate per 100 person-
years (95% CI)
15.0 (13.8–
16.2)
19.8 (17.6–22.0) 17.4 (14.0–20.7)
*Based on the woman’s report.
**Neisseria Gonorrhoea, Chlamydia trachomatis,Trichonomas vaginalis, or syphilis; Baseline STI and HSV-2 testing was not conducted within the
Partners Demonstration Project.
doi:10.1371/journal.pone.0145515.t001
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Table 2. Predictors of pregnancy in the derivation cohort.
Univariate models Multivariate model Stepwise multivariate model
HR (95% CI) p-
value
HR (95% CI) p-
value
HR (95% CI) p-value Regression
coefficient
Score
Age of woman (vs. 32)
18–27 4.13 (3.36–5.09) <0.001 4.87 (3.58–6.62) <0.001 4.09 (3.22–5.19) <0.001 1.41 6
28–31 2.38 (1.85–3.06) <0.001 2.71 (1.94–3.78) <0.001 2.50 (1.93–3.24) <0.001 0.92 4
Age of male partner (vs. 28)
18–24 2.23 (1.72–2.90) <0.001
25–27 1.95 (1.52–2.50) <0.001
Age difference (vs. male is 10 years
older)
Male is younger 0.70 (0.52–0.95) 0.023 1.10 (0.72–1.67) 0.7
Same age 0.55 (0.33–0.93) 0.024 0.77 (0.41–1.45) 0.4
Male is 1–5 years older 0.86 (0.69–1.08) 0.186 1.07 (0.80–1.43) 0.7
Male is 6–10 years older 0.98 (0.78–1.24) 0.885 1.19 (0.88–1.60) 0.3
Woman’s level of education, years
(vs. 5 years)
<1 year 0.88 (0.68–1.14) 0.341
1–4 years 0.92 (0.74–1.14) 0.451
Partnership duration of 1–6 years
(vs. <1 year or 6 years)
2.31 (1.95–2.73) <0.001 1.80 (1.41–2.30) <0.001 1.58 (1.30–1.91) <0.001 0.45 2
Married or cohabiting (vs. no) 1.36 (0.51–3.61) 0.537
Woman’s total number of children
(vs. 0–2 children)
3 0.79 (0.63–0.98) 0.035 1.42 (1.06–1.90) 0.02 1.29 (1.02–1.62) 0.0349 0.25 1
4 0.55 (0.45–0.66) <.001 1.49 (1.11–2.00) 0.008 1.56 (1.24–1.96) 0.0002 0.44 2
Number of children woman has
with her male study partner (vs. 0–
1)
2 0.93 (0.75–1.16) 0.534
3 0.53 (0.44–0.65) <.001
Number of sex acts with male
partner, past month
None 1.00
1–4 1.28 (0.73–2.72) 0.39 1.54 (0.67–3.52) 0.3
5–10 1.68 (0.95–2.99) 0.08 1.84 (0.80–4.25) 0.2
11–18 1.71 (0.93–3.13) 0.84 1.90 (0.81–4.46) 0.1
19 2.63 (1.38–5.02) 0.003 2.08 (0.81–5.29) 0.1
Condom use frequency with male
partner, past month (vs. 100%
condom use)
No sex with study partner 0.76 (0.43–1.34) 0.343
No condom use 1.63 (1.28–2.06) <0.001
Some condom use 1.50 (1.21–1.87) <0.001
Unprotected sex with male partner,
past month (vs. none)
1.57 (1.32–1.87) <0.001 1.45 (1.14–1.83) 0.003 1.63 (1.36–1.95) <0.001 0.49 2
Additional partner(s), past month
(vs. none)
0.42 (0.11–1.61) 0.203
Male partner circumcised (vs. not
circumcised)
Fully circumcised 0.93 (0.79–1.10) 0.398
(Continued)
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Among the categorical risk factors, having sex unprotected by a condom predicted only 33% of
pregnancies. In ROC analysis, the score (as the sole predictor) and the stepwise multivariate
model (with each predictor as a covariate) essentially overlapped, demonstrating that the score
captured essentially all of the predictability of the multivariate model. The area under the curve
(AUC) for the probability of the score to correctly predict pregnancy was 0.74 (95% CI 0.72–
0.76). Ten-fold cross validation produced an average AUC of 0.75 (95% CI: 0.65–0.80), indicat-
ing the internal robustness of the prediction algorithm.
For external validation, we applied the score to Kenyan and Ugandan participants in the
Partners in Prevention HSV/HIV Transmission Study and the Partners Demonstration Proj-
ect. Characteristics of couples in the validation datasets were similar to the derivation cohort
(Table 1) with trends towards younger ages, fewer children, and higher risk sexual behavior in
the Partners Demonstration Project, which was designed to recruit couples at higher risk for
HIV-1 transmission. [17, 24] The overall 12-month pregnancy incidence was 19.8 (95% CI
17.6–22.0) in the Partners in Prevention HSV/HIV Transmission Study and 17.4 (95% CI
14.0–20.7) in the Partners Demonstration Project.
In the Partners in Prevention HSV/HIV Transmission Study, 60.0% of the cohort had a
pregnancy likelihood score7 and couples in this range accounted for 250 (80.1%) of pregnan-
cies that were experienced. In the Partners Demonstration Project, 69.5% of the cohort had a
score7 and couples in this range accounted for 92.3% of the pregnancies experienced. Thus,
the score effectively identified a subset of each cohort with the highest pregnancy likelihood
and the great majority of the pregnancies were experienced by this subset. When the score was
applied to these external validation datasets, the AUC was 0.67 (95% CI 0.64–0.70) for the Part-
ners in Prevention HSV/HIV Transmission Study and 0.67 (95% CI 0.63–0.71) for the Partners
Demonstration Project.
The Partners Demonstration Project collected data at enrollment on fertility desires and
intentions. Using immediate fertility intention as a sole predictor of pregnancy (indicated by
saying “currently trying to get pregnant”) identified only 14% of pregnancies and the AUC was
poor at 0.53 (95% CI 0.50–0.56); reporting immediate fertility intention or within the next 3
years accounted for 62.5% of the pregnancies, with an AUC of 0.60 (0.55–0.64).
Table 2. (Continued)
Univariate models Multivariate model Stepwise multivariate model
HR (95% CI) p-
value
HR (95% CI) p-
value
HR (95% CI) p-value Regression
coefficient
Score
Partially circumcised 0.64 (0.15–2.62) 0.531
BV (vs. no BV) 1.16 (0.95–1.42) 0.152
Woman has infection with
gonorrhoea, chlamydia,
trichomonas and/or syphilis
1.19 (0.91–1.55) 0.20
Woman is HIV uninfected (vs. HIV-
infected)
0.61 (0.45–0.82) <0.001 0.86 (0.64–1.15) 0.3
HSV-2 uninfected (HIV uninfected
women only)
Indeterminate 1.49 (0.76–2.91) 0.248
Positive 0.61 (0.44–0.85) 0.003
No use of effective contraception
(vs. use of oral, injectable, IUD,
implant or surgical)
1.82 (1.52–2.19) <0.001 1.74 (1.38
(2.20)
<0.001 1.92 (1.59–2.32) <0.001 0.65 3
doi:10.1371/journal.pone.0145515.t002
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Fig 1. Pregnancy Likelihood Scorecard.
doi:10.1371/journal.pone.0145515.g001
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Discussion
We developed a pregnancy prediction scoring tool that can be used in research and clinical set-
tings to identify HIV-1 serodiscordant couples that are likely to become pregnant within one
year. In the current era of HIV-1 prevention, where antiretroviral interventions are incorpo-
rated into combination prevention strategies that nearly eliminate transmission within HIV-1
serodiscordant partnerships, efficient and cost-effective approaches are needed to identify and
target couples who are at highest risk of transmission, including those likely to become preg-
nant.[6, 22] Couples often lack opportunities to discuss pregnancy desires with their care
Fig 2. Pregnancy incidence rates by score among women in the A) Partners PrEP Study B) Partners in Prevention HSV/HIV Transmission Study at
Kenyan and Ugandan sites and C) Partners Demonstration Project.
doi:10.1371/journal.pone.0145515.g002
A Pregnancy Likelihood Score
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providers and many shy away from introducing the topic due to cultural stigma and the past
guidance for HIV infected women to avoid pregnancy.[25] Providers could use this tool to
engage HIV-1 serodiscordant couples in discussions about their fertility intentions, to
empower women and their partners to determine when/if they want to have children and to
receive the appropriate counseling and care that matches these desires, such as safer conception
services or the provision of effective contraception. Notably, the pregnancy score appeared to
be a better predictor than reported fertility intention. Thus, the tool could be used in conjunc-
tion with routine assessment of fertility desires to identify couples that might benefit most
from clinician-initiated discussion about couple and individual fertility goals and counseling
on how to achieve those goals. Depending on the clinic setting and goals, lower or higher cut-
points could be used to focus attention on couples with moderate, high, or extremely high preg-
nancy likelihood and balance the size of the population targeted with clinician time available
for counseling.
Fig 3. Receiver operating characteristic (ROC) curves for the pregnancy prediction score, individual continuous pregnancy predictors, and the
multivariate model containing all predictors.
doi:10.1371/journal.pone.0145515.g003
A Pregnancy Likelihood Score
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Clinical prediction tools are useful to identify novel cohorts for research on a specific out-
come or in a public health setting to triage individuals towards an individually-tailored inter-
vention. In the ongoing Partners Demonstration Project, the use of a validated scoring tool for
HIV-1 transmission successfully identified a high risk cohort with age, sexual behavior, and
plasma viral load characteristics indicative of much greater HIV-1 risk than our previous
cohorts.[24] Thus, in a research setting, these types of tools are useful and feasible to imple-
ment. Further operational research is needed to determine the feasibility of using these types
of tools in a public health clinic setting where patient burden is greater and provider time is
limited.
These data were from East African heterosexual HIV-1 serodiscordant couples and our
results are most applicable to HIV-1 serodiscordant couples in that context, with similar preg-
nancy rates and fertility intentions. Importantly, our cohort did not include women who do
not know their partner’s HIV-1 status, a group at potential risk for HIV-1 and pregnancy, and
in urgent need of interventions to reduce HIV-1 risk that are integrated with pregnancy plan-
ning. Also, our cohort included only HIV-1 serodiscordant couples but couples that are HIV-1
seroconcordant (positive or negative) can benefit from open discussion and counseling with
providers about fertility desires, pregnancy planning and their HIV-1 risks. We also do not
know that all pregnancies were fathered by the male partner enrolled in the study, but reports
of partnerships with men aside from those in the study were few and limiting follow-up to one
year after study enrollment reduces this limitation. A strength of our methods was the use of
multiple distinct cohorts to rigorously validate the prediction model and trends in pregnancy
rates across categories of the score.
Pregnancy planning, pre-conception care, and open discussions with partners and providers
are important, especially in the context of HIV-1 infection, to optimize pre-pregnancy health
and birth outcomes. [26] The integration of discussions about fertility intentions into HIV-1
programs is urgently needed, especially for HIV-1 serodiscordant couples struggling to under-
stand serodiscordance and to find ways to preserve their relationship in the midst of the risk of
HIV-1 transmission. Our scoring tool could provide such an opportunity, to identify couples
who have a high chance of becoming pregnant and increase dialogue about their best options
for meeting their immediate and long term fertility goals with the lowest possible HIV-1 risk.
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